CAS: 1143863-69-7
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | KBU2046 REF: IN-DA01W7THCAS: 1143863-69-7 | 97% | 183.00 €~309.00 € | Tue 26 Nov 24 |
 | KBU2046 REF: 7W-GW1807CAS: 1143863-69-7 | - - - | 136.00 €~606.00 € | Tue 03 Dec 24 |
 | KBU2046 REF: TM-T15646CAS: 1143863-69-7 | 99.87% | 34.00 €~1,099.00 € | Tue 03 Dec 24 |
 | KBU2046 REF: 3D-TVB86369CAS: 1143863-69-7 | Min. 98 Area-% | 206.00 €~1,047.00 € | Tue 10 Dec 24 |
Ref: 7W-GW1807
| 1mg | 136.00 € | ||
| 5mg | 271.00 € | ||
| 25mg | 606.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
KBU2046
CAS:1143863-69-7
KBU2046: oral anti-metastasis compound, enhances survival, targets chaperone complexes, not a typical HSP90 inhibitor.
Formula:
C15H11FO2
Purity:
99.87%
Color and Shape:
Solid
Molecular weight:
242.24
Ref: TM-T15646
| 2mg | 34.00 € | ||
| 5mg | 51.00 € | ||
| 10mg | 72.00 € | ||
| 25mg | 136.00 € | ||
| 50mg | 204.00 € | ||
| 100mg | 310.00 € | ||
| 200mg | 433.00 € | ||
| 1mL*10mM (DMSO) | 56.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
KBU2046
CAS:1143863-69-7
KBU2046 is a molecule that has been shown to increase the mitochondrial membrane potential in …
Formula:
C15H11FO2
Purity:
Min. 98 Area-%
Color and Shape:
Powder
Molecular weight:
242.2 g/mol
Ref: 3D-TVB86369
| 1mg | 206.00 € | ||
| 5mg | 730.00 € | ||
| 10mg | 1,047.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
